Identification of Hypoxia Signature to Assess the Tumor Immune Microenvironment and Predict Prognosis in Patients with Ovarian Cancer

Figure 8

Expression of immune checkpoints in the high and low hypoxia risk groups. (a) In the training cohort; (b) in the validation cohort.

(a)

(b)